These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7583513)

  • 1. Risperidone and NMS?
    Murray S; Haller E
    Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome with risperidone.
    Levin GM; Lazowick AL; Powell HS
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
    Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M
    Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
    Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
    J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
    Ghaffari N; Dossett E; Lee RH; Aghajanian P
    Obstet Gynecol; 2012 Feb; 119(2 Pt 2):436-438. PubMed ID: 22270430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA; Kuiper J; Verwey B
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel antipsychotics and neuroleptic malignant syndrome.
    Buckley P
    Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No recurrence of a neuroleptic malignant syndrome under quetiapine.
    Brieger P; Reinelt Y
    Aust N Z J Psychiatry; 2003 Oct; 37(5):627. PubMed ID: 14511095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.